The Robert TV Kung Interventional Heart Failure Fellowship Program Bringing Hope to the Hopeless at Tufts

Similar documents
The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities

Acute Mechanical Circulatory Support Right Ventricular Support Devices

Introduction to Acute Mechanical Circulatory Support

Case - Advanced HF and Shock (INTERMACS 1)

Matching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support

Acute Myocardial Infarction Complicated by Cardiogenic Shock

Bridging With Percutaneous Devices: Tandem Heart and Impella

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Circulatory Support: From IABP to LVAD

Recovering Hearts. Saving Lives.

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Acute Circulatory Support Should We or Shouldn t We?

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

Assist Devices in STEMI- Intra-aortic Balloon Pump

Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO)

The Epidemic of Heart Failure: Who is Certified to Care for these Patients?

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

Extra Corporeal Life Support for Acute Heart failure

DECLARATION OF CONFLICT OF INTEREST

Andrew Civitello MD, FACC

เอกราช อร ยะช ยพาณ ชย

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

Cardiogenic Shock and Initiatives to Reduce Mortality

Mechanics of Cath Lab Support Devices

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

Mechanical circulatory support in cardiogenic shock The Cardiologist s view ACCA Masterclass 2017

Cardiogenic Shock Protocol

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

Right Ventricular Failure: Prediction, Prevention and Treatment

Percutaneous Mitral Valve Repair

Device Therapy for Heart Failure

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know!

AllinaHealthSystem 1

Ted Feldman, M.D., MSCAI FACC FESC

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

Management of Acute Shock and Right Ventricular Failure

1/5/2017. The Next Frontier: Advanced Cardiogenic Shock U MICHIGAN EPERIENCE

Ventricular Assisting Devices in the Cathlab. Unrestricted

CABG for ischemic cardiomyopathy, post myocardial infarction and cardiogenic shock

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) Long Term Outcomes

Percutaneous Mechanical Circulatory Support Devices

Controversies in Cardiogenic Shock. Timothy D. Henry, MD Cedars-Sinai Heart Institute

PUMP FAILURE COMPLICATING AMI: ISCHAEMIC VSR

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

A National Cardiogenic Shock Initiative (CSI):

The Optimal Team for 24/7 CCU shock management

Cardiogenic Shock in Acute MI

MCS for Acute Heart Failure Eric Adler MD Associate Professor of Medicine Medical Director Cardiac Transplant

Update on Mechanical Circulatory Support. AATS May 5, 2010 Toronto, ON Canada

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

a case to support THE HEART & VASCULAR CENTER

The Heart Center Heart Failure and Transplant Program

Planned, Short-Term RVAD During Durable LVAD Implant: Indications and Management

ECMO and VAD implantation

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

GDMT for percutaneous mitral valve repair

Hardware in the Chest - From VADs to Valves

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI

Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella

Who is the high risk patient?

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Mechanics of Cath Lab Support Devices

Transcatheter Mitral Valve Repair and Replacement: Where is the Latest Randomized Evidence Taking US Mitral-Fr, COAPT

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Guideline compliance, utilization trends

Training Program Directors' Symposium Session: Critical Care Cardiology Training

LV Distension and ECLS Lungs

CARDIOLOGY GRAND ROUNDS

Vest Prevention of Early Sudden Death Trial (VEST)

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Innovative ECMO Configurations in Adults

Association between RV Function in PPCM and LV Recovery & Clinical Outcome

Ischemic Ventricular Septal Rupture

Prognostic Impact of FMR

APPLICATION FOR INTERVENTIONAL STRUCTURAL HEART DISEASE CARDIOLOGY FELLOWSHIP

Integrating Innovative Technologies into the Care of Cardiac Patients

Introducing the COAPT Trial

Non Pharmacological Treatment of the Acute Heart Failure

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg

Short and long term mechanical circulatory support: Management in intensive care. Dr Ana Hurtado Consultant Intensivist Harefield Hospital, UK

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012

Mitral Regurgitation

Understanding the Pediatric Ventricular Assist Device

Cath Lab Essentials: Basic Hemodynamics for the Cath Lab and ICU

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Total Artificial Hearts and Implantable Ventricular Assist Devices

ISHLT ACADEMY MASTER CLASS IN MECHANICAL CIRCULATORY SUPPORT (MCS)

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize

Ramani GV et al. Mayo Clin Proc 2010;85:180-95

The Case for Multivessel Revascularization in Shock

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD

Preliminary Programme

Bridge to Heart Transplantation

Right Heart Failure in LVAD patients: Prevention and Management.

UNIVERSITY OF OKLAHOMA INTERVENTIONAL CARDIOLOGY FELLOWSHIP CURRICULUM

APPLICATION FOR INTERVENTIONAL STRUCTURAL HEART DISEASE CARDIOLOGY FELLOWSHIP

Transcription:

The Robert TV Kung Interventional Heart Failure Fellowship Program Bringing Hope to the Hopeless at Tufts Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure Programs Executive Director, The Cardiovascular Center for Research & Innovation

One Patient s Interventional Heart Failure Experience AMI-Shock 10/2007 11/2007 Recurrent HF 11/2007 3/2008 HR-PCI 4/2009 Anterior MI LAD PCI and IABP LVEF 20% 7/2012 Readmitted Heart Failure LVEF 25% Recurrent HF 3/2015 Readmitted - HF ICD Implanted LVEF 25% 12/2017 Readmitted Recurrent HF LVEF 25% Advanced HF-Shock 12/2017 Readmitted HF/ACS Impella Supported LAD and LCx PCI LVEF 25% 4/2018 Readmitted Recurrent HF LVEF 20% Readmitted Recurrent HF LVEF 20% Cardiogenic Shock Impella + VA-ECMO LVEF 10% Cardiogenic Shock Biventricular Centrimags LVEF 10% Orthotopic Heart Transplant LVEF 65%

The Heart Failure Epidemic By the year 2030 1:33 individuals in the US will have heart failure

The Heart Failure Pandemic From AMI to Ischemic Heart Failure Top 10 Causes of Death Worldwide Terzic et al Trends in CV Med 2016 World Health Organization 2012

Heart Attacks Lead to Heart Failure 75% of AMI Patients Treated with Primary Reperfusion Develop Heart Failure Within 5 years 76% 39% 10% Ezekowitz JA et al JACC 2009

Longitudinal Care for our Cardiovascular Patients The Tufts Interventional Heart Failure (IHF) Program AHFS Acute MI Cardiogenic Shock High Risk PCI Cardiogenic Shock Advanced HF (BTD) Modified from Goodlin. JACC 2009;54:386

IHF Domain 1: Complex Coronary Revascularization It s Dead! It s Alive! Do not attempt PCI in this case without hemodynamic support.

IHF Domain 1: Complex Coronary Revascularization: 50 yo M with LVEF 15% and moderate to severe MR Advanced HF Cardiac Surgery Interventional Cross-boss Antegrade Dissection Re-entry Stingray Rahban Y (IHF 2017)

Advancing Intra-coronary Imaging Coronary Optical Coherence Tomography

Kuttab J; Aghili N; Rahban Y (IHF 2015-2017) IHF Domain 2: Valvular Heart Disease 75 yo M with LVEF 25% and severe MR + Porcelain Aorta Advanced HF Cardiac Surgery Interventional Before Repair After Repair 30-50% of HF patients have MR Optimizing GDMT including CRT MitraClip Average 60-70 minutes/case

IHF Domain 2: Valvular Heart Disease 75 yo M with LVEF 25% and severe MR + Porcelain Aorta Advanced HF Cardiac Surgery Interventional Before Repair After Repair Interventional Team Navin Kapur Carey Kimmelstiel Andrew Weintraub Jen Eaton/Kristina Booher Rich Botto/Gavin Adams Advanced HF Team Ayan Patel Amanda Vest Michael Kiernan David DeNofrio/Jim Udelson Marvin Konstam/Fred Chen Clinical Teams Cath Lab Nursing CCU/N6 Nursing Teams Vilma Castaneda Ryan O Kelly Frank Polakovich (Abbott)

IHF Domain 2: Valvular Heart Disease 85 year old with inoperable Aortic Valve Stenosis Advanced HF Cardiac Surgery Interventional Andrew Weintraub, MD

IHF Domain 3: Holes in the Heart Closing holes in the heart to reduce stroke risk Carey Kimmelstiel, MD David Thaler, MD

IHF Domain 3: Holes in the Heart Opening holes to reduce symptoms of heart failure REDUCE LAP TRIAL Carey Kimmelstiel, MD Amanda Vest, MD

IHF Domain 4: Hypertrophic Cardiomyopathy Tufts is the Largest HCM Program in the United States Martin Maron, MD

IHF Domain 5: Mechanical Circulatory Support 2007 2017 IVADs HVAD Impella CP TH-RVAD TH + 5.0 Impella 5.0 CP RP BiPellas 5.0 as a Bridge to Recovery

IHF Domain 5: Mechanical Circulatory Support Bi-VADs HVAD Impella CP Bi-Pellas Cardiac Replacement Cardiac Recovery Delivering patients back to their lives and our neighborhoods

IHF Domain 6: Mechanical Circulatory Support Catheter-based Approaches for LVAD Failure

Kapur and Upshaw et al. JCTVS 2014 IHF Domain 6: Mechanical Circulatory Support Catheter-based Approaches for LVAD Failure

IHF Domain 7: Advanced Hemodynamics Kapur et al ASAIO 2014

Korabathina and Kapur et al. CCI 2009 Morine and Kapur et al. J Card Fail 2014 Tedford R and Kass DA. Circulation 2012;125:289-297 IHF Domain 7: Advanced Hemodynamics Effect of elevated pulmonary capillary wedge pressure (PCWP) on pulmonary vascular resistance-compliance relationship (RPA-CPA). Pulm. Venous Congestion PCWP PA Compliance PA Resistance PAPi = PA Pulse Pressure Right Atrial Pressure

IHF Domain 8: Translational Research Boston Paris Rome Barcelona 2015 2017 Clinical Excellence Preclinical Testing Fundamental Discoveries Preclinical DTU Trial Clinical DTU Trial Launch

The Robert TV Kung Interventional HF Program Training the Next Generation of IHF Leaders at Tufts MC * Funding provided for an ACGME Adv HF Fellow and a Research Fellow per academic year

The Robert TV Kung Interventional HF Program Training the Next Generation of IHF Leaders at Tufts MC Mission Statement: To advance the training mission of the CVC by providing interventional cardiology fellows with an opportunity to train in advanced heart failure and cardiac transplant medicine, thereby combining technical and cognitive skills to optimize patient care and generate new approaches to clinical research, innovation, and education.

The Robert TV Kung Interventional HF Program Training the Next Generation of IHF Leaders at Tufts MC Kung Clinical Fellow (2019) Kung Clinical Fellow (2020) Kung Research Fellow (2019)